Antiviral Drug Resistance in the Age of Emerging Viral Infections
Received Date: Jul 20, 2023 / Published Date: Aug 28, 2023
Abstract
The emergence of new viral infections, such as COVID-19, Ebola, and Zika, has underscored the importance of effective antiviral treatments. However, the development of antiviral drug resistance presents a formidable challenge to managing these emerging infections. This article examines the intricate interplay between antiviral drug resistance and emerging viral infections. It delves into the factors contributing to resistance development, the susceptibility of emerging infections to resistance, and strategies to mitigate this phenomenon. By exploring the multifaceted nature of antiviral drug resistance in the context of emerging viral threats, this article highlights the urgent need for comprehensive approaches to ensure the continued efficacy of antiviral therapies.
Citation: Saeed H (2023) Antiviral Drug Resistance in the Age of Emerging Viral Infections. J Cell Mol Pharmacol 7: 165. Doi: 10.4172/jcmp.1000165
Copyright: © 2023 Saeed H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 1789
- [From(publication date): 0-2023 - Apr 04, 2026]
- Breakdown by view type
- HTML page views: 1405
- PDF downloads: 384
